XML 39 R22.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY
 12 Months Ended
Sep. 30, 2021
Equity [Abstract]  
EQUITY EQUITY
Authorized and issued shares consisted of the following (in millions):
September 30,
20212020
Preferred shares, no par value:
Authorized0.2 shares0.2 shares
Issued0.0 shares0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized100.0 shares100.0 shares
Issued68.1 shares68.1 shares
In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2021, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 26% of Scotts Miracle-Gro’s outstanding Common Shares on a fully diluted basis and, thus, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.
Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100% of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.
Accumulated Other Comprehensive Loss
Changes in AOCL by component were as follows for the fiscal years ended September 30:
 Foreign Currency Translation AdjustmentsNet Unrealized Gain (Loss) On Derivative InstrumentsNet Unrealized Loss On SecuritiesNet Unrealized Gain (Loss) in Pension and Other Post-Retirement BenefitsAccumulated Other Comprehensive Income (Loss)
Balance at September 30, 2018 $(8.7)$8.3 $— $(45.6)$(46.0)
Other comprehensive income (loss) before reclassifications(11.2)(20.1)— (15.0)(46.3)
Amounts reclassified from accumulated other comprehensive net income (loss)2.5 (2.0)— 2.8 3.3 
Income tax benefit (expense)— 5.7 — 3.2 8.9 
Net current period other comprehensive income (loss)(8.7)(16.4)— (9.0)(34.1)
Adoption of new accounting pronouncements— — — (13.8)(13.8)
Balance at September 30, 2019(17.4)(8.1)— (68.4)(93.9)
Other comprehensive income (loss) before reclassifications10.5 (19.7)— (12.9)(22.1)
Amounts reclassified from accumulated other comprehensive net income (loss)0.8 10.1 — 0.3 11.2 
Income tax benefit (expense)— 2.5 — 3.2 5.7 
Net current period other comprehensive income (loss)11.3 (7.1)— (9.4)(5.2)
Balance at September 30, 2020(6.2)(15.1)— (77.8)(99.1)
Other comprehensive income (loss) before reclassifications4.5 26.8 (3.1)6.9 35.1 
Amounts reclassified from accumulated other comprehensive net income (loss)— 7.3 — 0.4 7.7 
Income tax benefit (expense)— (8.9)0.8 (1.9)(10.0)
Net current period other comprehensive income (loss)4.5 25.2 (2.3)5.4 32.8 
Balance at September 30, 2021$1.7 $10.2 $(2.3)$72.5 $(66.4)
The sum of the components may not equal due to rounding.
Dividends
On July 27, 2020, the Scotts Miracle-Gro Board of Directors approved an increase in the Company’s quarterly cash dividend from $0.58 to $0.62 per Common Share. In addition, on July 27, 2020, the Scotts Miracle-Gro Board of Directors approved a special cash dividend of $5.00 per Common Share, which was paid on September 10, 2020 to all shareholders of record at the close of business on August 27, 2020. On July 30, 2021, the Scotts Miracle-Gro Board of Directors approved an increase in the Company’s quarterly cash dividend from $0.62 to $0.66 per Common Share, which was first paid in the fourth quarter of fiscal 2021.
Share Repurchases
On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the share repurchase authorization through March 28, 2020. The amended authorization allowed for repurchases of Common Shares of up to an aggregate amount of $1,000.0 through March 28, 2020. During fiscal 2020 through March 28, 2020, Scotts Miracle-Gro repurchased 0.4 million Common Shares under this share repurchase authorization for $48.2. There were no share repurchases under this share repurchase authorization during fiscal 2019. From the effective date of this share repurchase authorization in the fourth quarter of fiscal 2014 through March 28, 2020, Scotts Miracle-Gro repurchased approximately 8.7 million Common Shares for $762.8.
On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. The authorization provides the Company with flexibility to purchase Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization may be suspended or discontinued by the Board of Directors at any time, and there can be no guarantee as to the timing or amount of any repurchases. There were no share repurchases under this share repurchase authorization during fiscal 2020. During fiscal 2021, Scotts Miracle-Gro repurchased 0.6 million Common Shares under this share repurchase authorization for $113.1. The “Treasury share purchases” lines in the Consolidated Statements of Shareholders’ Equity includes cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $16.3, $4.9 and $2.7 for fiscal 2021, fiscal 2020 and fiscal 2019, respectively.
Share-Based Awards
A maximum of 7.3 million Common Shares are available for issuance under share-based award plans. At September 30, 2021, approximately 2.6 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.4 million, 0.4 million and 0.5 million were reissued in support of share-based compensation awards and employee purchases under the employee stock purchase plan during fiscal 2021, fiscal 2020 and fiscal 2019, respectively. Performance-based award units with performance periods ending September 30, 2021 achieved a weighted average of 240 percent of the target performance share units granted and will result in the reissuance of 1.2 million Common Shares held in treasury, and a corresponding reduction in the number of shares available to underlie new share-based awards in the future, upon vesting during fiscal 2022.
The following is a summary of the share-based awards granted during each of the periods indicated:
 Year Ended September 30,
 202120202019
Employees
Options183,553 37,255 — 
Restricted stock units70,936 119,726 166,534 
Performance units1,903 37,570 131,644 
Non-Employee Directors
Restricted and deferred stock units9,173 18,948 32,101 
Total share-based awards265,565 213,499 330,279 
Aggregate fair value at grant dates$30.2 $21.5 $25.5 
Total share-based compensation was as follows for each of the periods indicated:
 Year Ended September 30,
 202120202019
Share-based compensation$40.6 $57.9 $38.4 
Related tax benefit recognized7.4 14.6 9.5 
Excess tax benefits related to share-based compensation were $18.3, $5.8 and $2.8 for fiscal 2021, fiscal 2020 and fiscal 2019, respectively.
Stock Options
Stock option activity was as follows:
No. of
  Options		Wtd.
Avg.
Exercise
Price
Awards outstanding at September 30, 2020619,225 $57.90 
Granted183,553 236.53 
Exercised(234,587)51.18 
Awards outstanding at September 30, 2021568,191 118.38 
Exercisable384,638 62.00 

At September 30, 2021, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was $3.7, which is expected to be recognized over a weighted-average period of 2.3 years. The total intrinsic value of stock options exercised was $41.8, $21.9 and $17.5 during fiscal 2021, fiscal 2020 and fiscal 2019, respectively. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $15.2, $17.6 and $21.4 for fiscal 2021, fiscal 2020 and fiscal 2019, respectively. The following summarizes certain information pertaining to stock option awards outstanding and exercisable at September 30, 2021:
 Awards OutstandingAwards Exercisable
Range of
Exercise Price		No. of
Options		Wtd.
Avg.
Remaining
Life		Wtd.
Avg.
Exercise
Price		No. of
Options		Wtd.
Avg.
Remaining
Life		Wtd.
Avg.
Exercise
Price
$42.60 - $42.60
3,706 0.30$42.60 3,706 0.30$42.60 
$59.62 - $64.55
380,932 3.8562.18 380,932 3.8562.18 
$236.53 - $236.53
183,553 9.35236.53 — 0.00— 
568,191 5.60118.38 384,638 3.8262.00 
The intrinsic values of the stock option awards outstanding and exercisable at September 30, 2021 were as follows: 
 2021
Outstanding$32.4 
Exercisable32.4 
The weighted average assumptions for stock option awards granted in fiscal 2021 are as follows:
Expected market price volatility31.9 %
Risk-free interest rate0.7 %
Expected dividend yield1.8 %
Expected life of stock options in years6.06
Estimated weighted-average fair value per stock option$61.15 
Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:
No. of
Shares		Wtd. Avg.
Grant Date
Fair Value
per Share
Awards outstanding at September 30, 2020500,237 $94.53 
Granted80,109 230.95 
Vested(194,105)92.70 
Forfeited(10,416)96.54 
Awards outstanding at September 30, 2021375,825 124.50 
At September 30, 2021, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was $11.3, which is expected to be recognized over a weighted-average period of 1.8 years. The total fair value of restricted stock units and deferred stock units vested was $41.8, $15.2 and $6.3 during fiscal 2021, fiscal 2020 and fiscal 2019, respectively.
Performance-based awards
Performance-based award activity was as follows (based on target award amounts):
No. of
Units		Wtd. Avg.
Grant Date
Fair Value
per Unit
Awards outstanding at September 30, 2020666,128 $92.85 
Granted1,903 236.53 
Vested (a)
(26,729)87.99 
Forfeited(68,745)95.49 
Awards outstanding at September 30, 2021572,557 95.09 

(a)Vested at a weighted average of 196 percent of the target performance share units granted.
At September 30, 2021, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based units not yet recognized was $8.6, which is expected to be recognized over a weighted-average period of 0.9 years. The total fair value of performance-based units vested was $11.9 during fiscal 2021 and $3.9 during fiscal 2020 and fiscal 2019